Enterococcus faecium SF68® (SF68®) is considered one of the best characterized probiotic active ingredient worldwide. The strain has been isolated in Sweden from a healthy newborn baby in the sixties and selected for further use thanks to its favorable probiotic characteristics. The pharmacological properties and safety profile of SF68 have been extensively studied. The efficacy of SF68 in the prevention and treatment of intestinal disorders has been confirmed in many double blind clinical trials.
Products based on SF68 are available in many countries all over the world. In Europe the most important products are marketed under the trademark Bioflorin® in Austria, Italy and Switzerland.
CERBIOS has long lasting customers receiving SF68® in form of standardized active ingredients in dry form or intermediates. However, since 2008, CERBIOS is fully equipped to supply pharmaceutical finished products based on SF68® in form of hard gelatin capsules in glass bottles.
In this form CERBIOS can grant a shelf life of 18 months at room temperature following ICH guidelines